Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging technology company specializing in PET and PET-CT imaging systems and clinical services is pleased to ...
Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced that it has won the Innovation Award in the PET-CT Imaging ...
Constantinos G. Vayenas examines positron and electron catalysis of neutrino hadronization, as they continue to explore how ...
Pharmaceutical Technology® spoke with Juliana Maynard, PhD, Head of Translational Imaging, at Medicines Discovery Catapult, ...
Kate Shemirani’s conduct of care towards her daughter Paloma has been described as ‘incomprehensible’ by a coroner ...
She co-created the French Atomic Energy Commission in 1945 and held a six-year term, promoting nuclear research and ...
Down syndrome is associated with accelerated aging. It is estimated that up to 90% of individuals with the condition develop ...
(Reuters) -Low-dose radiotherapy is a safe, effective treatment for mild-to-moderate osteoarthritis, three research teams ...
Alzheimer's disease is a heartbreaking and complicated condition, slowly taking away memory, thinking, and independence.
Facilities that make particles called B mesons may seem obscure, but they could help explain why there is more matter than ...
A less invasive test for Alzheimer’s is a big advance. But it’s not perfect and is not meant to screen healthy people.
Burlington-based Labcorp has launched the first blood-based test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the diagnosis of Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results